Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.5437
-0.0563 (-9.38%)
At close: Dec 19, 2025
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of $619.74 million as of December 19, 2025. Its market cap has increased by 518.22% in one year.
Market Cap
619.74M
Enterprise Value
726.47M
Revenue
189.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.54
Market Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 296.29M to 619.74M, an increase of 109.17%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 635.95M | 207.77% |
| Dec 31, 2024 | 206.63M | 498.26% |
| Dec 29, 2023 | 34.54M | 69.69% |
| Dec 30, 2022 | 20.35M | -90.69% |
| Dec 31, 2021 | 218.67M | 51.51% |
| Dec 31, 2020 | 144.33M | 59.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.80M |
| Glass House Brands | 731.06M |
| Elite Pharmaceuticals | 521.70M |
| Northwest Biotherapeutics | 387.57M |
| CytoDyn | 359.70M |
| Silence Therapeutics | 294.27M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 198.84M |